Literature DB >> 19809211

Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart.

Hideki Otake1, Hitoshi Suzuki, Takashi Honda, Yukio Maruyama.   

Abstract

Diabetes mellitus (DM) is clinically associated with an increased incidence of atrial fibrillation (AF), but the underlying mechanism remains unclear. We hypothesized that neural remodeling enhances AF vulnerability in diabetic hearts. Eight weeks after creating streptozotocin-induced diabetic rats (DM rats) or control rats, the hearts were perfused according to the Langendorff method. Inducibility of AF was evaluated by 5 times burst pacing from the right atrium and the atrial effective refractory period (AERP) was measured. The protocol was repeated during sympathetic nerve stimulation (SNS) or parasympathetic nerve stimulation (PNS). In tissue samples taken from the right atrium, the density of nerves positive for tyrosine hydroxylase (TH) and acetylcholinesterase (AChE) were determined. SNS significantly increased the incidence of AF in DM rats (14 +/- 6 to 30 +/- 8%, P < 0.01), but not in control rats (11 +/- 4 to 14 +/- 6%, NS). Although AERP was significantly decreased by SNS in both rats (each P < 0.01), increased heterogeneity of AERP by SNS was seen only in DM rats. PNS significantly decreased AERP and increased the incidence of AF (9 +/- 5 to 30 +/- 5% in control rats, 12 +/- 6 to 27 +/- 6% in DM rats, each P < 0.01) in both rats. The density of TH-positive nerves was heterogeneous in DM rats compared with control rats, whereas the heterogeneity of AChE-positive nerves was not different in the rats. The prevalence of AF was enhanced by adrenergic activation in diabetic hearts, in which heterogeneous sympathetic innervation was evident. These results suggest that neural remodeling may play a crucial role for increased AF vulnerability in DM.

Entities:  

Mesh:

Year:  2009        PMID: 19809211     DOI: 10.1536/ihj.50.627

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  38 in total

1.  The p75 neurotrophin receptor, semaphorins, and sympathetic traffic in the heart.

Authors:  Bruce D Carter; Ning Feng; Nazareno Paolocci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-19       Impact factor: 4.733

2.  Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart.

Authors:  Kristina Rysevaite; Inga Saburkina; Neringa Pauziene; Sami F Noujaim; José Jalife; Dainius H Pauza
Journal:  Heart Rhythm       Date:  2010-11-12       Impact factor: 6.343

3.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

Review 4.  Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and Interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 5.  Role of diabetes in heart rhythm disorders.

Authors:  Buelent Koektuerk; Murat Aksoy; Marc Horlitz; Ilkay Bozdag-Turan; Ramazan Goekmen Turan
Journal:  World J Diabetes       Date:  2016-02-10

6.  Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy.

Authors:  B Stratmann; D Tschöpe
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

7.  QTc interval predicts outcome of catheter ablation in paroxysmal atrial fibrillation patients with type 2 diabetes mellitus.

Authors:  Ning Ma; Xiao-Yan Wu; Chang-Sheng Ma; Nian Liu; Rong Bai; Xin Du; Yan-Fei Ruan; Jian-Zeng Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

8.  Sitagliptin Modulates the Electrical and Mechanical Characteristics of Pulmonary Vein and Atrium.

Authors:  Chien-Jung Chang; Ten-Fang Yang; Tin-I Lee; Yao-Chang Chen; Yu-Hsun Kao; Shih-Ann Chen; Yi-Jen Chen
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

Review 9.  Prediction of atrial fibrillation development and progression: Current perspectives.

Authors:  Konstantinos Vlachos; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Stamatis Georgopoulos; Athanasios Bakalakos; Nikolaos Karamichalakis; Sotirios Xydonas; Michael Efremidis; Antonios Sideris
Journal:  World J Cardiol       Date:  2016-03-26

10.  Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease.

Authors:  Jannik Langtved Pallisgaard; Maria Mori Brooks; Bernard R Chaitman; Derek B Boothroyd; Marco Perez; Mark A Hlatky
Journal:  Am J Med       Date:  2018-03-23       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.